Spring FGS Meeting Highlight: Unveiling STELARA® (ustekinumab) As A First Line Biologic Option with Real-World Evidence
Join us for an exclusive live educational program at the upcoming Spring FGS Meeting, featuring esteemed Gastroenterologist Dr. Ronen Arai from Digestive CARE of N. Broward, Coral Springs, FL.
Dr. Arai will delve into the cutting-edge treatment STELARA® (ustekinumab), showcasing its efficacy as a first-line biologic option for adults with moderately to severely active Crohn’s Disease (CD) and Ulcerative Colitis (UC).
Event Details:
Location: Naples Grande Beach Resort, 475 Seagate Dr, Naples, FL 34103
Date & Time: Saturday, March 9, 2024, 12:30 PM – 1:30 PM Eastern
Why STELARA®?
STELARA® stands at the forefront of biologic treatments for CD and UC, offering hope to those who have not found relief with traditional therapies.
Dr. Arai’s presentation will cover:
- The uniquely designed dosing regimen of STELARA®.
- Examine real-world evidence supporting its use as a first-line biologic option in CF2 and UC in adult patients who failed or were intolerant to immunomodulators or corticosteroids.
- Comprehensive review of efficacy and safety data.
RSVP Today:
Secure your spot at this pivotal session by registering at www.mydomeprogramregistration.com with the Meeting Code: 2024-00583.
Don’t miss this opportunity to gain insights into STELARA® directly from a leading specialist in the field.
Please Note: This session is sponsored by Janssen Biotech, Inc., and is designed to be both informative and compliant with all relevant guidelines, ensuring that attendees receive the most accurate and up-to-date information.
We look forward to welcoming you to this enlightening session and to providing an avenue for enhanced patient care through innovative treatment options.
